This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Data Remove Medical Evaluation Remove Policy Related Topics
State Laws DEA Decriminalization Collective Compliance Extraction Safety Oil Marijuana Cannabinoids More Related Topics >
article thumbnail

I Have Some Thoughts on This Biden Cannabis Play

Canna Law Blog

OCTOBER 12, 2022

Based upon it’s “scientific and medical evaluation”, the FDA found marijuana supremely dangerous and formally recommended that the plant remain in schedule I. It’s true that cannabis study data have continued to accrue over the past seven years. Fundamentally, however, things are no different than in 2015.

Legislation 84
Legislation Decriminalization Medical Evaluation Cannabis 84
article thumbnail

Further Consideration of the STATES Act

Cannabis Law Report

MARCH 25, 2019

Both paths are complex processes in which scientific, medical, policy and political forces have influence. The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). 1] professionals.

Banking 45
Banking Law Marijuana State Laws 45
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024